Ignite Creation Date:
2024-05-06 @ 6:41 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05747716
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-02-28
First Post:
2023-02-18
Brief Title:
SBRT Combined With Fruquintinib Plus PD-1CTLA-4 Antibody for Third-line Treatment in mCRC
Sponsor:
Organization:
Wuhan Union Hospital China